Cargando…
Active surveillance in metastatic pancreatic neuroendocrine tumors: A 20-year single-institutional experience
BACKGROUND: Pancreatic neuroendocrine tumors (PanNETs) are heterogeneous and indolent; systemic therapy is not essential for every patient with metastatic PanNET. The National Comprehensive Cancer Network guidelines state that delaying treatment is an option for PanNET with distant metastasis, if th...
Autores principales: | Gao, He-Li, Wang, Wen-Quan, Xu, Hua-Xiang, Wu, Chun-Tao, Li, Hao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479574/ https://www.ncbi.nlm.nih.gov/pubmed/32953851 http://dx.doi.org/10.12998/wjcc.v8.i17.3751 |
Ejemplares similares
-
Tumor-infiltrating platelets predict postoperative recurrence and survival in resectable pancreatic neuroendocrine tumor
por: Xu, Shuai-Shuai, et al.
Publicado: (2019) -
Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer
por: Xu, Shuai-Shuai, et al.
Publicado: (2020) -
Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers
por: Zhou, Rui-Quan, et al.
Publicado: (2019) -
Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors
por: Chen, Hong-Yu, et al.
Publicado: (2020) -
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors
por: Paiella, Salvatore, et al.
Publicado: (2017)